Lars Tanum
R&D Department, P.O. Box 1000
1478, Norway
1478, Norway
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 59 publications
Genetic Influence on Extended-Release Naltrexone Treatment Outcomes in Patients with Opioid Use Disorder: An Exploratory Study.
Journal: Brain sciences
Published: December 12, 2025
Changes in quality of life during 52 weeks of extended-release naltrexone treatment, subsequent by a 1-year post-treatment period.
Journal: Drug and alcohol dependence
Published: July 16, 2025
Chronic Pain and Posttraumatic Stress Among Patients in Substance Use Treatment: Protocol for NOR-APT, a Longitudinal Cohort Study.
Journal: JMIR research protocols
Published: June 30, 2025
Mortality during and following treatment with extended-release naltrexone based on data from two clinical trials.
Journal: Drug and alcohol dependence
Published: April 26, 2025
Measuring Personal Recovery in a Sample of People with Opioid Use Disorder: Psychometric Properties of the Norwegian Version of the Questionnaire about the Process of Recovery.
Journal: European addiction research
Published: March 21, 2025
Reward Sensitivity in Patients Receiving Opioid Agonist and Antagonist Treatment for Opioid Use Disorder: An Observational Study.
Journal: Biological psychiatry. Cognitive neuroscience and neuroimaging
Published: February 06, 2025
Pain intensity in patients using extended-release naltrexone or opioid agonists and its effect on extended-release naltrexone treatment outcomes.
Journal: The American journal on addictions
Published: December 12, 2024
Pain Intensity in Patients with Opioid Use Disorder on Extended-Release Naltrexone or Opioid Agonists; The Role of COMT rs4680 and OPRM1 rs1799971: An Exploratory Study.
Journal: Journal of pain research
Published: October 15, 2024
Comparative Analysis of Lysophosphatidic Acid Levels in Fibromyalgia and Other Painful Conditions in Female Patients.
Journal: European journal of pain (London, England)
Published: October 14, 2024
Changes in mental health during long-term treatment with extended-release naltrexone: A 3-year clinical study of opioid dependent individuals.
Journal: Contemporary clinical trials
Published: June 18, 2024
Patients with Opioid Use Disorder Choosing Treatment with Extended-Release Naltrexone: A 6-Month Naturalistic Study.
Journal: European addiction research
Published: June 10, 2024
High induction rate onto extended-release naltrexone for people with opioid use disorder: experiences from a Norwegian naturalistic study.
Journal: Addiction science & clinical practice
Published: March 26, 2024
Last Updated: 09/26/2026